BACKGROUND: Delirium can be hypothesized to be an extreme manifestation of sickness behavior in elderly persons with neurodegenerative disease. The purpose of this study was to investigate whether increased cerebral inflammation with microglial, astrocyte, and cytokine activation exists in patients with delirium compared to nondelirious patients. METHODS: Postmortem brain tissue from 9 cases with delirium was compared to 6 age-matched controls without delirium. Human leukocyte antigen-DR (HLA-DR) and CD68 cell count and glial fibrillary acidic protein (GFAP), interleukin-1β (IL-1β), IL-6,β-amyloid, and tau protein immunoreactivity were determined in hippocampus, frontal cortex, and white matter. RESULTS: There were no significant differences in the patients with delirium compared to the controls with respect to age 73 versus 70.5 years (p=0.72) or dementia (22% versus 0%, p=0.22). Both markers for microglial activity showed significantly higher scores in delirium brain specimens than controls in the total brain score (HLA-DR 129 vs. 20 and CD68 30 vs. 8.5) as well as in the various brain areas separately. The immunoreactivity of astrocyte activity (GFAP) was higher in the total brain score in patients with delirium (5.2 vs. 4.0, p=0.05), but in the various brain areas this was only significant in the dentate gyrus. IL-6 immunoreactivity was higher in patients with delirium in all brain areas and IL-1β was not detectable. Coexisting infectious disease or dementia did not influence the overall results. CONCLUSIONS: These preliminary study results show an association between human brain activity of microglia, astrocytes, and IL-6 and delirium in elderly patients and add to the accumulating evidence that inflammatory mechanisms are involved in delirium.
BACKGROUND:Delirium can be hypothesized to be an extreme manifestation of sickness behavior in elderly persons with neurodegenerative disease. The purpose of this study was to investigate whether increased cerebral inflammation with microglial, astrocyte, and cytokine activation exists in patients with delirium compared to nondelirious patients. METHODS: Postmortem brain tissue from 9 cases with delirium was compared to 6 age-matched controls without delirium. Human leukocyte antigen-DR (HLA-DR) and CD68 cell count and glial fibrillary acidic protein (GFAP), interleukin-1β (IL-1β), IL-6,β-amyloid, and tau protein immunoreactivity were determined in hippocampus, frontal cortex, and white matter. RESULTS: There were no significant differences in the patients with delirium compared to the controls with respect to age 73 versus 70.5 years (p=0.72) or dementia (22% versus 0%, p=0.22). Both markers for microglial activity showed significantly higher scores in delirium brain specimens than controls in the total brain score (HLA-DR 129 vs. 20 and CD68 30 vs. 8.5) as well as in the various brain areas separately. The immunoreactivity of astrocyte activity (GFAP) was higher in the total brain score in patients with delirium (5.2 vs. 4.0, p=0.05), but in the various brain areas this was only significant in the dentate gyrus. IL-6 immunoreactivity was higher in patients with delirium in all brain areas and IL-1β was not detectable. Coexisting infectious disease or dementia did not influence the overall results. CONCLUSIONS: These preliminary study results show an association between human brain activity of microglia, astrocytes, and IL-6 and delirium in elderly patients and add to the accumulating evidence that inflammatory mechanisms are involved in delirium.
Authors: Clarice Luz; Fabiana Dornelles; Thales Preissler; Diego Collaziol; Ivana M da Cruz; Moisés E Bauer Journal: Mech Ageing Dev Date: 2003 Aug-Sep Impact factor: 5.432
Authors: Barbara C van Munster; Johanna C Korevaar; Aeilko H Zwinderman; Marcel Levi; W Joost Wiersinga; Sophia E De Rooij Journal: J Am Geriatr Soc Date: 2008-08-04 Impact factor: 5.562
Authors: Carol Murray; David J Sanderson; Chris Barkus; Robert M J Deacon; J Nicholas P Rawlins; David M Bannerman; Colm Cunningham Journal: Neurobiol Aging Date: 2010-05-14 Impact factor: 4.673
Authors: C Smith; S M Gentleman; P D Leclercq; L S Murray; W S T Griffin; D I Graham; J A R Nicoll Journal: Neuropathol Appl Neurobiol Date: 2013-10 Impact factor: 8.090
Authors: Sarinnapha M Vasunilashorn; Simon T Dillon; Sharon K Inouye; Long H Ngo; Tamara G Fong; Richard N Jones; Thomas G Travison; Eva M Schmitt; David C Alsop; Steven D Freedman; Steven E Arnold; Eran D Metzger; Towia A Libermann; Edward R Marcantonio Journal: J Am Geriatr Soc Date: 2017-05-26 Impact factor: 5.562
Authors: Charles H Brown; Laura Max; Andrew LaFlam; Lou Kirk; Alden Gross; Rakesh Arora; Karin Neufeld; Charles W Hogue; Jeremy Walston; Aliaksei Pustavoitau Journal: Anesth Analg Date: 2016-08 Impact factor: 5.108
Authors: Oluwaseun Akeju; Lauren E Hobbs; Lei Gao; Sara M Burns; Kara J Pavone; George S Plummer; Elisa C Walsh; Tim T Houle; Seong-Eun Kim; Matt T Bianchi; Jeffrey M Ellenbogen; Emery N Brown Journal: Clin Neurophysiol Date: 2017-10-20 Impact factor: 3.708
Authors: Charles H Brown; Julia Probert; Ryan Healy; Michelle Parish; Yohei Nomura; Atsushi Yamaguchi; Jing Tian; Kenton Zehr; Kaushik Mandal; Vidyulata Kamath; Karin J Neufeld; Charles W Hogue Journal: Anesthesiology Date: 2018-09 Impact factor: 7.892